Georgia's governor said Wednesday that he wants to spend $1.8 billion to unclog one of traffic-choked Atlanta's notorious ...

A Kaiser Family Foundation study revealed about one in eight adults in the US say they’re taking a GLP-1 drug such as Ozempic ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

FDA moves to strike suicide risk warnings from Saxenda, Wegovy, and Zepbound labels after analysis finds no increased risk.

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely ...

Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

Agency officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs used ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...